DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jin, J | - |
dc.contributor.author | Lee, WS | - |
dc.contributor.author | Joo, KM | - |
dc.contributor.author | Maiti, KK | - |
dc.contributor.author | Biswas, G | - |
dc.contributor.author | Kim, W | - |
dc.contributor.author | Kim, KT | - |
dc.contributor.author | Lee, SJ | - |
dc.contributor.author | Kim, KH | - |
dc.contributor.author | Nam, DH | - |
dc.contributor.author | Chung, SK | - |
dc.date.accessioned | 2015-06-25T02:38:55Z | - |
dc.date.available | 2015-06-25T02:38:55Z | - |
dc.date.created | 2011-06-16 | - |
dc.date.issued | 2011-04 | - |
dc.identifier.issn | 2040-2503 | - |
dc.identifier.other | 2015-OAK-0000023674 | en_US |
dc.identifier.uri | https://oasis.postech.ac.kr/handle/2014.oak/11366 | - |
dc.description.abstract | The per oral administration of compound 1, prepared by covalently attaching paclitaxel to a molecular carrier, shows good anti-tumor activity in the orthotopic mouse model of glioblastoma. The anti-tumor effects may be attributable to the cytotoxicity as well as the anti-angiogenic activity of the paclitaxel conjugate or paclitaxel itself in the brain parenchyma. | - |
dc.description.statementofresponsibility | open | en_US |
dc.language | English | - |
dc.publisher | ROYAL SOC CHEMISTRY | - |
dc.relation.isPartOf | MEDCHEMCOMM | - |
dc.rights | BY_NC_ND | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/2.0/kr | en_US |
dc.title | Preparation of blood-brain barrier-permeable paclitaxel-carrier conjugate and its chemotherapeutic activity in the mouse glioblastoma model | - |
dc.type | Article | - |
dc.contributor.college | 융합생명공학부 | en_US |
dc.identifier.doi | 10.1039/C0MD00235F | - |
dc.author.google | Jin, J | en_US |
dc.author.google | Lee, WS | en_US |
dc.author.google | Chung, SK | en_US |
dc.author.google | Nam, DH | en_US |
dc.author.google | Kim, KH | en_US |
dc.author.google | Lee, SJ | en_US |
dc.author.google | Kim, KT | en_US |
dc.author.google | Kim, W | en_US |
dc.author.google | Biswas, G | en_US |
dc.author.google | Maiti, KK | en_US |
dc.author.google | Joo, KM | en_US |
dc.relation.volume | 2 | en_US |
dc.relation.issue | 4 | en_US |
dc.relation.startpage | 270 | en_US |
dc.relation.lastpage | 273 | en_US |
dc.contributor.id | 10104775 | en_US |
dc.relation.journal | MEDCHEMCOMM | en_US |
dc.relation.index | SCI급, SCOPUS 등재논문 | en_US |
dc.relation.sci | SCIE | en_US |
dc.collections.name | Journal Papers | en_US |
dc.type.rims | ART | - |
dc.identifier.bibliographicCitation | MEDCHEMCOMM, v.2, no.4, pp.270 - 273 | - |
dc.identifier.wosid | 000290697800004 | - |
dc.date.tcdate | 2019-01-01 | - |
dc.citation.endPage | 273 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 270 | - |
dc.citation.title | MEDCHEMCOMM | - |
dc.citation.volume | 2 | - |
dc.contributor.affiliatedAuthor | Kim, KT | - |
dc.identifier.scopusid | 2-s2.0-79953873279 | - |
dc.description.journalClass | 1 | - |
dc.description.journalClass | 1 | - |
dc.description.wostc | 12 | - |
dc.description.scptc | 13 | * |
dc.date.scptcdate | 2018-10-274 | * |
dc.type.docType | Article | - |
dc.subject.keywordPlus | CONTAINING MOLECULAR TRANSPORTERS | - |
dc.subject.keywordPlus | P-GLYCOPROTEIN INHIBITOR | - |
dc.subject.keywordPlus | MULTIDRUG-RESISTANCE | - |
dc.subject.keywordPlus | TAXOL | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | DESIGN | - |
dc.subject.keywordPlus | TUMORS | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
library@postech.ac.kr Tel: 054-279-2548
Copyrights © by 2017 Pohang University of Science ad Technology All right reserved.